|
ELK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.047590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63156999999359E-05 |
| Normal-vs-Stage2 |
5.612100E-02 |
| Normal-vs-Stage3 |
3.309000E-01 |
| Normal-vs-Stage4 |
3.209600E-01 |
| Stage1-vs-Stage2 |
3.936000E-01 |
| Stage1-vs-Stage3 |
1.336760E-01 |
| Stage1-vs-Stage4 |
4.168600E-01 |
| Stage2-vs-Stage3 |
5.350600E-01 |
| Stage2-vs-Stage4 |
8.919600E-01 |
| Stage3-vs-Stage4 |
7.377600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.67760000000716E-05 |
| Normal-vs-AfricanAmerican |
3.557900E-03 |
| Normal-vs-Asian |
2.940900E-03 |
| Caucasian-vs-AfricanAmerican |
6.415600E-01 |
| Caucasian-vs-Asian |
1.412770E-01 |
| AfricanAmerican-vs-Asian |
3.733000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56721999999831E-05 |
| Normal-vs-Female |
3.223400E-01 |
| Male-vs-Female |
2.020900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.847800E-04 |
| Normal-vs-Extreme_Weight |
7.35230000215026E-08 |
| Normal-vs-Obese |
6.672200E-02 |
| Normal-vs-Extreme_Obese |
1.63054999999801E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.239600E-01 |
| Normal_Weight-vs-Obese |
1.231790E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.378400E-02 |
| Extreme_Weight-vs-Obese |
1.044440E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.964840E-01 |
| Obese-vs-Extreme_Obese |
6.961800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.265400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.860420E-03 |
| Normal-vs-Age(61-80Yrs) |
4.20660000000073E-05 |
| Normal-vs-Age(81-100Yrs) |
1.68199998373808E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.356600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.885760E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.659700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.47260000002725E-06 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.344200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04879999999852E-05 |
| Normal-VS-Type2 PRCC |
3.93619999927708E-08 |
| Normal-VS-KIRP CIMP |
6.431900E-02 |
| Normal-VS-Unclassified PRCC |
2.501400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.898600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.040090E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.234400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.041400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.575900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.432400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08250000022225E-07 |
| Normal-vs-N1 |
9.893800E-01 |
| Normal-vs-N2 |
7.331400E-01 |
| N0-vs-N1 |
2.154100E-02 |
| N0-vs-N2 |
2.802600E-01 |
| N1-vs-N2 |
7.123000E-01 |
|
|
